Ready 8-Ks
3
Latest filing
July 21, 2026, 4:30 PM ET
Top materiality
0.55
Event mix
leadership ×1 · other ×1 · other_material ×1
Sentiment
0 pos · 0 neg · 3 neu
Recent 8-K filings for PLYX
Highest-materiality recent filing
Polaryx closes $10M PIPE at ~$4.00/share to fund Phase 2 SOTERIA basket trial
- Private placement of 2,502,696 common shares at avg $4.00/share for $10M gross proceeds to ~35 investors.
- Largest stockholder MStone Partners Healthcare purchased 88,453 shares ($360k) in the offering.
-
Polaryx Therapeutics CMO Lisa Bollinger resigns effective immediately
CMO Lisa Bollinger, MD, resigned on July 19, 2026, effective immediately.
-
Polaryx sets 2026 annual meeting for Sept 10; record date July 27
Annual meeting will be held virtually on September 10, 2026.
-
Polaryx closes $10M PIPE at ~$4.00/share to fund Phase 2 SOTERIA basket trial
Private placement of 2,502,696 common shares at avg $4.00/share for $10M gross proceeds to ~35 investors.
Materiality & sentiment trend
Max materiality 0.55 · Median 0.40 · Most common event leadership